摘要
背景:长期应用阿片受体治疗疼痛会导致药物耐受或成瘾,可能与delta阿片受体密度上调有关。目的:设计及构建大鼠delta阿片受体短发卡RNA真核表达载体并鉴定。方法:根据大鼠delta阿片受体mRNA序列设计并体外合成短发卡RNA寡核苷酸片段,退火形成双链,克隆到线性化质粒pGenesil-1,然后进行酶切和测序鉴定。结果与结论:酶切证明delta阿片受体-短发卡RNA已经插入到质粒载体pGenesil-1里,测序结果证明均为插入正确的克隆质粒,而且质量均符合设计标准,证实靶向大鼠delta阿片受体基因的短发卡RNA真核表达载体构建成功。
BACKGROUND:Long-term application of opioid receptor for treatment of pains would cause drug tolerance or addiction,which is possibly related to upregulated delta opioid receptor(DOR) density.OBJECTIVE:To design and construct short hairpin RNA(shRNA) eukaryotic expression plasmids targeting DOR gene which may play an important role in morphine tolerance.METHODS:Three pairs of short chain oligonucleotides targeted to rat DOR mRNA(Accession No:NM_012617) were designed and synthesized individually based on the sequence of rat DOR mRNA at first.Then the synthestic sense and antisense oligonucleotide strands were mixed together in annealing buffer to form 3 DNA duplexes.Subsequently,the DNA segments were cloned into pGenesil-1.2 vectors respectively.At last,the plasmids were identified by restriction analysis and sequencing test.RESULTS AND CONCLUSION:The results of restriction analysis and sequencing test showed that all three designed DOR shRNA-expression duplexes were successfully inserted into the plasmid vector pGenesil-1.2 respectively and recombinant plasmid vectors were constructed meeting our aims.The DOR-shRNA expression vectors were constructed successfully and could be used in RNAi's study on morphine tolerance.
出处
《中国组织工程研究与临床康复》
CAS
CSCD
北大核心
2011年第46期8668-8670,共3页
Journal of Clinical Rehabilitative Tissue Engineering Research
基金
国家自然科学基金项目(30872440)
下调δ受体同时特异性激活μ2受体后的镇痛效应评价~~